133 related articles for article (PubMed ID: 10373635)
1. Tenascin expression in gastric cancer with special emphasis on the WHO-, Lauren-, and Goseki-classifications.
Zirbes TK; Baldus SE; Moenig SP; Schmitz K; Thiele J; Holscher AH; Dienes HP
Int J Mol Med; 1999 Jul; 4(1):39-42. PubMed ID: 10373635
[TBL] [Abstract][Full Text] [Related]
2. [Prognostic value of histologic classifications of advanced stomach cancer: comparative study of Lauren's and Goseki's classifications].
Guglielmi A; de Manzoni G; Tomezzoli A; Ricci F; Pelosi G; Laterza E; Di Leo A; Bonfiglio M
Chir Ital; 1997; 49(3):45-9. PubMed ID: 9612652
[TBL] [Abstract][Full Text] [Related]
3. Relationship between immunoexpression of mucin peptide cores MUC1 and MUC2 and Lauren's histologic subtypes of gastric carcinomas.
Barresi V; Vitarelli E; Grosso M; Tuccari G; Barresi G
Eur J Histochem; 2006; 50(4):301-9. PubMed ID: 17213039
[TBL] [Abstract][Full Text] [Related]
4. How do gastric carcinoma classification systems relate to mucin expression patterns? An immunohistochemical analysis in a series of advanced gastric carcinomas.
Gürbüz Y; Kahlke V; Klöppel G
Virchows Arch; 2002 May; 440(5):505-11. PubMed ID: 12021925
[TBL] [Abstract][Full Text] [Related]
5. Preferential overexpression of CD44v5 in advanced gastric carcinoma Goseki grades I and III.
Stachura J; Krzeszowiak A; Popiela T; Urbańczyk K; Pituch-Noworolska A; Wieckiewicz J; Zembala M
Pol J Pathol; 1999; 50(3):155-61. PubMed ID: 10624117
[TBL] [Abstract][Full Text] [Related]
6. The prognostic significance of the mucin phenotype of gastric adenocarcinoma and its relationship with histologic classifications.
Lee OJ; Kim HJ; Kim JR; Watanabe H
Oncol Rep; 2009 Feb; 21(2):387-93. PubMed ID: 19148512
[TBL] [Abstract][Full Text] [Related]
7. Correlation of the immunohistochemical reactivity of mucin peptide cores MUC1 and MUC2 with the histopathological subtype and prognosis of gastric carcinomas.
Baldus SE; Zirbes TK; Engel S; Hanisch FG; Mönig SP; Lorenzen J; Glossmann J; Fromm S; Thiele J; Pichlmaier H; Dienes HP
Int J Cancer; 1998 Apr; 79(2):133-8. PubMed ID: 9583726
[TBL] [Abstract][Full Text] [Related]
8. Cytokeratin expression patterns of gastric carcinomas according to Lauren and Goseki classification.
Gürbüz Y; Köse N
Appl Immunohistochem Mol Morphol; 2006 Sep; 14(3):303-8. PubMed ID: 16932021
[TBL] [Abstract][Full Text] [Related]
9. Histological grading in gastric cancer by Goseki classification: correlation with histopathological subtypes and prognosis.
Mönig S; Baldus SE; Collet PH; Zirbes TK; Bollschweiler E; Thiele J; Dienes HP; Hölscher AH
Anticancer Res; 2001; 21(1B):617-20. PubMed ID: 11299815
[TBL] [Abstract][Full Text] [Related]
10. Classification of gastric carcinoma using the Goseki system provides prognostic information additional to TNM staging.
Songun I; van de Velde CJ; Arends JW; Blok P; Grond AJ; Offerhaus GJ; Hermans J; van Krieken JH
Cancer; 1999 May; 85(10):2114-8. PubMed ID: 10326687
[TBL] [Abstract][Full Text] [Related]
11. Lack of prognostic significance in Goseki grading of gastric carcinoma.
Ventura L; Chiominto A; Discepoli S; Ventura T; Di Giacomo C; Leocata P
J Exp Clin Cancer Res; 2002 Jun; 21(2):225-7. PubMed ID: 12148582
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological Variation of Lauren Classification in Gastric Cancer.
Chen YC; Fang WL; Wang RF; Liu CA; Yang MH; Lo SS; Wu CW; Li AF; Shyr YM; Huang KH
Pathol Oncol Res; 2016 Jan; 22(1):197-202. PubMed ID: 26502923
[TBL] [Abstract][Full Text] [Related]
13. [Correlation of histological classifications of gastric carcinomas with location and prognosis].
Calli Demirkan N; Tunçyürek M; Ugur Ertan E; Bülent Alkanat M; Içöz G
Gastroenterol Clin Biol; 2002; 26(6-7):610-5. PubMed ID: 12193861
[TBL] [Abstract][Full Text] [Related]
14. Goseki grading in gastric cancer: comparison with existing systems of grading and its reproducibility.
Dixon MF; Martin IG; Sue-Ling HM; Wyatt JI; Quirke P; Johnston D
Histopathology; 1994 Oct; 25(4):309-16. PubMed ID: 7835835
[TBL] [Abstract][Full Text] [Related]
15. Lauren's and Goseki's grade distribution does not change along with the progression from an early to advanced gastric carcinoma.
Stachura J; Popiela T; Kulig J; Urbańczyk K; Heitzman J
Pol J Pathol; 1998; 49(3):151-3. PubMed ID: 9810173
[TBL] [Abstract][Full Text] [Related]
16. Relationships between mucinous gastric carcinoma, MUC2 expression and survival.
Leteurtre E; Zerimech F; Piessen G; Wacrenier A; Leroy X; Copin MC; Mariette C; Aubert JP; Porchet N; Buisine MP
World J Gastroenterol; 2006 Jun; 12(21):3324-31. PubMed ID: 16733847
[TBL] [Abstract][Full Text] [Related]
17. [Goseki classification in adenocarcinoma of the cardia].
De Manzoni G; Pedrazzani C; Di Leo A; Bonfiglio M; Zerman G; Tasselli S; Borzellino G
Minerva Chir; 2002 Aug; 57(4):449-55. PubMed ID: 12145574
[TBL] [Abstract][Full Text] [Related]
18. Goseki grade and tumour location influence survival of patients with gastric cancer.
Calik M; Calik I; Demirci E; Altun E; Gundogdu B; Sipal S; Gundogdu C
Asian Pac J Cancer Prev; 2014; 15(3):1429-34. PubMed ID: 24606478
[TBL] [Abstract][Full Text] [Related]
19. Co-expression of CDX2 and MUC2 in gastric carcinomas: correlations with clinico-pathological parameters and prognosis.
Roessler K; Mönig SP; Schneider PM; Hanisch FG; Landsberg S; Thiele J; Hölscher AH; Dienes HP; Baldus SE
World J Gastroenterol; 2005 Jun; 11(21):3182-8. PubMed ID: 15929165
[TBL] [Abstract][Full Text] [Related]
20. Mucin antigen expression in gastric carcinomas of young and old adults.
Sakamoto H; Yonezawa S; Utsunomiya T; Tanaka S; Kim YS; Sato E
Hum Pathol; 1997 Sep; 28(9):1056-65. PubMed ID: 9308730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
